This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event
In-Person: October 11-13 • Virtual: October 18-20Hyatt Regency • New Brunswick, NJ

Ron Hartmann, PharmD
Vice President, Pharmacy Solutions at Sagent Pharmaceuticals


Ron Hartmann, PharmD, is currently Vice President, Pharmacy Solutions at Sagent Pharmaceuticals, supporting Sagent’s National Accounts, Business Development, Contracting, DSCSA, Senior Management and Sales teams. He also serves as Sagent’s primary 340B resource and provides support for Sagent’s 503B partner, SterRx.

Before joining Sagent in 2016, Dr. Hartmann spent nearly 16 years in the GPO industry, leading the pharmacy program at MedAssets. His clinical practice and management experience includes 10 years at the Washington Hospital Center in Washington, DC, followed by 7 years with the Sisters of Mercy Health System, St. Louis. While at Mercy, he served as director of pharmacy at what is now Mercy Hospital St. Louis and was corporate director of pharmacy for Unity Health.

Dr. Hartmann earned his bachelor’s degree in biology from the University of California, Irvine, and his PharmD from the University of Southern California. He completed a clinical pharmacy residency in general medicine through the Philadelphia College of Pharmacy and Science at the Hospital of the University of Pennsylvania.

Agenda Sessions

  • The Role of HRSA's 340B Prime Vendor